COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
2.500
-0.200 (-7.41%)
At close: Dec 20, 2024, 4:00 PM
2.600
+0.100 (4.00%)
After-hours: Dec 20, 2024, 4:00 PM EST
COSCIENS Biopharma Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Net Income | -23.21 | -16.55 | -22.73 | -8.37 | -5.12 | -6.04 | Upgrade
|
| Depreciation & Amortization | 0.3 | 0.17 | 0.14 | 0.15 | 0.23 | 0.32 | Upgrade
|
| Other Amortization | - | - | - | - | 0.73 | 0.55 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.55 | -0.55 | - | -0 | -0 | 0.01 | Upgrade
|
| Asset Writedown & Restructuring Costs | 1.46 | - | 8.35 | - | -0.52 | 0.7 | Upgrade
|
| Stock-Based Compensation | 0.66 | 0.38 | 0.54 | 0.31 | 0.06 | 0.79 | Upgrade
|
| Other Operating Activities | -1.85 | 0.47 | -0.59 | -3.17 | -1.91 | -4.61 | Upgrade
|
| Change in Accounts Receivable | -2.87 | 0.15 | 0.59 | 0.12 | -1.02 | -0.37 | Upgrade
|
| Change in Inventory | 2.05 | 0.16 | -0.16 | -0.06 | 1.18 | -0.97 | Upgrade
|
| Change in Accounts Payable | -0.5 | 0.08 | 1.08 | 0.63 | 0.05 | -0.62 | Upgrade
|
| Change in Unearned Revenue | -1.21 | -1.42 | 0.44 | 3.01 | 3.03 | 0.74 | Upgrade
|
| Change in Income Taxes | - | - | - | -0.11 | 0.4 | -0.19 | Upgrade
|
| Change in Other Net Operating Assets | -1.47 | 0 | -1.34 | -1.1 | -1.23 | -1.04 | Upgrade
|
| Operating Cash Flow | -27.19 | -17.12 | -13.68 | -8.58 | -4.13 | -10.73 | Upgrade
|
| Capital Expenditures | -0.74 | -0.02 | -0.01 | -0.03 | - | - | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | 0 | 0.01 | - | Upgrade
|
| Sale (Purchase) of Intangibles | 0.55 | 0.55 | - | -0.61 | - | - | Upgrade
|
| Other Investing Activities | 0.21 | -0 | -0 | -0.02 | 0.05 | 0.05 | Upgrade
|
| Investing Cash Flow | 26.06 | 0.53 | -0.01 | -0.66 | 0.06 | 0.05 | Upgrade
|
| Long-Term Debt Repaid | - | -0.15 | -0.13 | -0.13 | -0.27 | -0.61 | Upgrade
|
| Net Debt Issued (Repaid) | -0.26 | -0.15 | -0.13 | -0.13 | -0.27 | -0.61 | Upgrade
|
| Issuance of Common Stock | - | - | - | 54.29 | 23.5 | 1.85 | Upgrade
|
| Other Financing Activities | -0.07 | - | 0.02 | -3.12 | -2.77 | 2.66 | Upgrade
|
| Financing Cash Flow | -0.35 | -0.15 | -0.12 | 51.04 | 20.47 | 3.89 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.02 | 0.15 | -0.88 | -0.77 | 0.04 | 0.11 | Upgrade
|
| Net Cash Flow | -1.45 | -16.6 | -14.69 | 41.03 | 16.43 | -6.67 | Upgrade
|
| Free Cash Flow | -27.93 | -17.14 | -13.69 | -8.61 | -4.13 | -10.73 | Upgrade
|
| Free Cash Flow Margin | -577.70% | -380.99% | -242.75% | -163.71% | -113.06% | -2015.98% | Upgrade
|
| Free Cash Flow Per Share | -17.19 | -14.12 | -11.28 | -7.49 | -10.05 | -61.30 | Upgrade
|
| Cash Income Tax Paid | - | -1.33 | -0.83 | 1.61 | 1.45 | - | Upgrade
|
| Levered Free Cash Flow | -13.87 | -10.21 | -9.01 | -4.75 | -3.35 | -5.96 | Upgrade
|
| Unlevered Free Cash Flow | -13.87 | -10.2 | -9.01 | -4.75 | -3.35 | -5.59 | Upgrade
|
| Change in Net Working Capital | 1.39 | 0.02 | 0.06 | -0.85 | 0.67 | 1.18 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.